UHT · Universal Health Realty Income Trust - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $99.19M | $99.01M | $95.58M | $90.63M | $84.19M | $78.01M |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - |
| Total Operating Expenses | $64.43M | $62.22M | $64.23M | $59.96M | $55.33M | $52.01M |
| D&A | $28.86M | $27.42M | $27.73M | $26.56M | $27.48M | $25.58M |
| Operating Income | $34.76M | $36.80M | $31.35M | $30.67M | $28.86M | $26.00M |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - |
| Net Income | $17.61M | $19.23M | $15.40M | $21.10M | $109.17M | $19.45M |
| EPS - Basic | $1.27 | $1.39 | $1.12 | $1.53 | $7.94 | $1.42 |
| EPS - Diluted | $1.27 | $1.39 | $1.11 | $1.53 | $7.92 | $1.41 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.69M | $7.10M | $8.21M | $7.61M | $22.50M | $5.74M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $564.91M | $580.86M | $596.37M | $607.54M | $598.42M | $494.01M |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | $374.77M | $368.41M | $359.66M | $343.05M | $329.05M | $295.43M |
| Total Liabilities | $412.52M | $401.32M | $395.44M | $378.44M | $363.09M | $335.00M |
| Stockholders' Equity | $152.38M | $179.54M | $200.93M | $229.10M | $235.33M | $159.00M |
| Retained Earnings | $862.90M | $845.29M | $826.06M | $810.66M | $789.56M | $680.73M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $49.09M | $46.91M | $42.94M | $46.80M | $47.73M | $44.21M |
| Investing Cash Flow | ($14.96M) | ($13.88M) | ($19.11M) | ($36.67M) | ($24.43M) | ($27.21M) |
| Financing Cash Flow | ($34.55M) | ($34.15M) | ($23.23M) | ($25.02M) | ($6.54M) | ($17.37M) |
| CapEx | - | - | $7.62M | $13.62M | $12.99M | $2.27M |
| Free Cash Flow | - | - | $35.32M | $33.19M | $34.74M | $41.94M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 35.0% | 37.2% | 32.8% | 33.8% | 34.3% | 33.3% |
| EBITDA margin | 64.1% | 64.9% | 61.8% | 63.1% | 66.9% | 66.1% |
| Net margin | 17.8% | 19.4% | 16.1% | 23.3% | 129.7% | 24.9% |
| Free cash flow margin | - | - | 37.0% | 36.6% | 41.3% | 53.8% |
| FCF / Net income | - | - | 2.29 | 1.57 | 0.32 | 2.16 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | 3.1% | 3.3% | 2.6% | 3.5% | 18.2% | 3.9% |
| Return on equity | 11.6% | 10.7% | 7.7% | 9.2% | 46.4% | 12.2% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | 2.46 | 2.05 | 1.79 | 1.50 | 1.40 | 1.86 |
| Debt / Assets | 0.66 | 0.63 | 0.60 | 0.56 | 0.55 | 0.60 |
| Debt / EBITDA | 5.89 | 5.74 | 6.09 | 6.00 | 5.84 | 5.73 |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | 3.71 | 3.24 | 2.97 | 2.65 | 2.54 | 3.11 |
| Liabilities / Assets | 0.73 | 0.69 | 0.66 | 0.62 | 0.61 | 0.68 |
| Efficiency | ||||||
| Asset turnover | 0.18 | 0.17 | 0.16 | 0.15 | 0.14 | 0.16 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 30.9x | 26.8x | 39.0x | 31.2x | 7.5x | 45.6x |
| P / B | 3.6x | 2.9x | 3.0x | 2.9x | 3.5x | 5.6x |
| P / S | 5.5x | 5.2x | 6.3x | 7.3x | 9.7x | 11.3x |
| EV / EBITDA | 14.3x | 13.6x | 16.1x | 17.4x | 20.0x | 22.8x |
| Growth | ||||||
| Revenue growth (YoY) | 0.2% | 3.6% | 5.5% | 7.6% | 7.9% | 1.1% |
| Revenue CAGR (3y) | 3.1% | 5.6% | 7.0% | 5.5% | 3.4% | 2.5% |
| Revenue CAGR (5y) | 4.9% | 5.1% | 4.6% | 4.6% | 4.6% | 4.1% |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | -5.5% | 17.4% | 2.2% | 6.2% | 11.0% | 1.0% |
| Net income growth (YoY) | -8.4% | 24.9% | -27.0% | -80.7% | 461.4% | 2.5% |
| EPS growth (YoY) | -8.6% | 25.2% | -27.5% | -80.7% | 461.7% | 2.2% |
| EPS CAGR (3y) | -6.0% | -44.0% | -7.7% | 3.5% | 65.1% | -25.1% |
| EPS CAGR (5y) | -2.1% | 0.1% | -8.8% | -14.5% | 44.0% | -4.6% |
| FCF growth (YoY) | - | - | 6.4% | -4.5% | -17.2% | 11.7% |
| FCF CAGR (5y) | - | - | -0.8% | -2.1% | - | 14.4% |
| Book value growth (YoY) | -15.1% | -10.6% | -12.3% | -2.6% | 48.0% | -12.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$99.19M totalReportable Segment Aggregation Before Other Operating Segment$99.19M · 100.0%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- -Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing UNIVERSAL HEALTH REALTY INCOME TRUST against the 5 most active filers in the same SIC group.
Dividends
$2.97/share trailing 12 months · +1.4% YoY
| Ex-date | Per share |
|---|---|
| Mar 23, 2026 | $0.7450 |
| Dec 22, 2025 | $0.7450 |
| Sep 22, 2025 | $0.7400 |
| Jun 23, 2025 | $0.7400 |
| Mar 24, 2025 | $0.7350 |
| Dec 16, 2024 | $0.7350 |
| Sep 16, 2024 | $0.7300 |
| Jun 17, 2024 | $0.7300 |
| Mar 15, 2024 | $0.7250 |
| Dec 18, 2023 | $0.7250 |
| Sep 18, 2023 | $0.7200 |
| Jun 16, 2023 | $0.7200 |
| Mar 17, 2023 | $0.7150 |
| Dec 15, 2022 | $0.7150 |
| Sep 16, 2022 | $0.7100 |
| Jun 16, 2022 | $0.7100 |
| Mar 18, 2022 | $0.7050 |
| Dec 14, 2021 | $0.7050 |
| Sep 17, 2021 | $0.7000 |
| Jun 15, 2021 | $0.7000 |
| Mar 16, 2021 | $0.6950 |
| Dec 16, 2020 | $0.6950 |
| Sep 15, 2020 | $0.6900 |
| Jun 15, 2020 | $0.6900 |